Psychological variables associated with quality of life

following primary treatment for head and neck cancer: a

systematic review of the literature from 2004 to 2015 by Dunne, Simon et al.
Review
Psychological variables associated with quality of life
following primary treatment for head and neck cancer: a
systematic review of the literature from 2004 to 2015
Simon Dunne1, Orla Mooney1, Laura Coffey2, Linda Sharp3, Deirdre Desmond2, Conrad Timon4, Eleanor O’Sullivan5
and Pamela Gallagher1*
1Dublin City University, Dublin, Ireland
2Maynooth University, Maynooth, County Kildare, Ireland
3Newcastle University, Newcastle, UK
4St. James’s Hospital, Dublin, Ireland
5Cork University Dental School and Hospital, Cork, Ireland
*Correspondence to:
School of Nursing and Human
Sciences, Dublin City University,
Glasnevin, Dublin 9, Ireland.
E-mail: pamela.gallagher@dcu.ie
Received: 15 October 2015
Revised: 28 January 2016
Accepted: 4 February 2016
Abstract
Objective: There has been a recent proliferation of research on quality of life (QoL) in head and neck
cancer (HNC). The objective of this review was to systematically examine the evidence on psycholog-
ical factors associated with QoL outcomes for HNC survivors in the post-treatment period published
during 2004–2015.
Methods: Five databases were searched for studies investigating psychological factors associated
with QoL in HNC survivors. Empirical studies published between January 2004 and June 2015 were
included if they measured QoL as an outcome following treatment using a reliable and valid measure,
examined its association with at least one psychological factor and included at least 50 HNC survivors.
Results: Twenty-four publications describing 19 studies (9 cross-sectional, 10 prospective) involving
2,263 HNC survivors were included. There was considerable heterogeneity in study design and diver-
sity in measurement and analysis. Distress-related variables (depression, anxiety, distress) were most
frequently investigated, and mostly reported negative associations with QoL outcomes. Associations
were also observed between other psychological factors (e.g., coping, neuroticism and fear of recur-
rence) and QoL.
Conclusions: Several psychological factors predict QoL among HNC survivors who have completed
treatment. Routine screening and early interventions that target distress could improve HNC survi-
vors’ QoL following treatment. Longitudinal and population-based studies incorporating more sys-
tematic and standardised measurement approaches are needed to better understand relationships
between psychological factors and QoL and to inform the development of intervention and supportive
care strategies.
Copyright © 2016 John Wiley & Sons, Ltd.
Background
Head and neck cancer (HNC) refers to a group of related
neoplasms of the oral cavity, pharynx, larynx, nasal
cavity, middle ear and sinuses [1]. HNC constitutes the
seventh most commonly diagnosed cancer and the seventh
most common cause of death from cancer worldwide with
approximately 686 000 new diagnoses and 376 000 esti-
mated deaths in 2012 [2]. Treatment for HNC typically in-
volves surgery, radiation therapy, chemotherapy or a
combination thereof. Such treatments are often aggressive
and can severely impact survivors’ quality of life (QoL)
[3–5], for example, through visible disfigurement and
functional difficulties relating to eating, breathing and
speech [6–8].
Quality of life1 is a multifaceted construct describing
individuals’ ‘physical health, psychological state, level
of independence, social relationships and relationships to
salient features in their environment’ [9]. QoL is an impor-
tant outcome in HNC [3,4,10,11]; it assesses the impact of
diagnosis and treatment from the perspective of the patient
[12] and has a strong positive relationship to survival
[13,14]. QoL may also be a particularly important out-
come for HNC survivorship; research has consistently
identified clinical and functional issues that negatively
influence QoL following HNC treatment, including
xerostomia, sticky saliva, cancer-related fatigue, visible
disfigurement and impairments in speech, taste/smell,
swallowing and sexual functioning [8]. Although some
of these issues improve over time following HNC
Copyright © 2016 John Wiley & Sons, Ltd.
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treatment, many persist 12 months after treatment and can
profoundly impact HNC survivors’ psychological well-
being [5]. A recent narrative review highlighted potentially
modifiable psychological factors that may be associated with
lower QoL among HNC survivors who have finished pri-
mary treatment, including heightened distress, body image
concerns, fear of recurrence (FoR) and the use of avoidant
coping strategies [6]. This research implicates the potential
importance of psychological factors in predicting the QoL
of HNC survivors.
A systematic review published in 2005 [15] examining
behavioural and psychosocial predictors of QoL in HNC
survivors found that psychosocial predictors including
depression, personality, social support and satisfaction with
consultant information were significantly associated with
QoL in this population. The authors underscored the pres-
ence of inconclusive findings for certain psychological
predictors (e.g. perceived social support) and a dearth of
studies on others (e.g. coping), highlighting the need for
further high-quality research on psychological predictors of
QoL. Since 2005, there has been a proliferation of HNC
QoL research. Following these considerations, we
undertook a systematic review to examine the current state
of the evidence on psychological factors associated with
QoL among HNC survivors who had completed their
primary treatment. In particular, we aimed to identify the as-
sociations between psychological variables (i.e. variables re-
lating to individuals’ cognitive and/or emotional processes)
measured before, during or after HNC treatment and QoL
outcomes measured following HNC treatment. Identifying
psychological variables associated with post-treatment QoL
could aid in the early identification of those at risk for poorer
outcomes (e.g. those with particular personality styles) and
inform the development of interventions to promote QoL
in this population (e.g. by focusing on the training of key
psychological skills, which may be modifiable).
Methods
Search strategy
In line with preferred reporting items for systematic reviews
and meta-analyses (PRISMA) guidelines [16], a systematic
search of the literature on QoL in HNC was conducted
using five databases: MEDLINE, CINAHL, PsycINFO,
EMBASE and Web of Science (all Core Collection:
Citation Indexes & Chemical Indexes). Four of these data-
bases (MEDLINE, CINAHL, PsycINFO and EMBASE)
were searched using controlled vocabulary search terms
for HNC and QoL. The fifth database, Web of Science,
was searched using analogous free text search terms derived
from [15] (Supporting Information). All searches were
limited to include only literature published in the English
language during 01 January 2004 to 08 June 2015. The
reference lists of included articles were also manually
searched for any additional articles. Figure 1 illustrates the
number of papers identified, screened, assessed for eligibil-
ity and included in this review.
Selection criteria
Detailed inclusion and exclusion criteria are provided in
Table 1. We defined HNC as neoplasms of the oral cavity,
larynx, pharynx, nasal cavity, middle ear and sinuses only.
All articles describing studies that exclusively comprised
HNC survivors with cancers of the face (e.g. basal cell carci-
nomas), lip, ears, eyes or thyroid were excluded. This review
focussed on survivors in the post-primary treatment phase as
this is considered a ‘teachable moment’ within which inter-
ventions to aid psychological well-being may be targeted
[3]. All empirical papers investigating the relationship be-
tween QoL among HNC patients following primary treat-
ment and at least one psychological variable were deemed
eligible; articles that did not clearly report that all participants
had received or finished primary treatment for HNC were in-
eligible. We defined psychological variables as variables
comprising individuals’ cognitive and/or emotional processes
and used this definition to guide the application of our
inclusion/exclusion criteria. Following Llewellyn et al. [15],
articles were excluded if QoL measurement was limited to
functional status, or a measure of disfigurement only, or in-
volved the use of a distress-specific instrument such as the
Hospital Anxiety and Depression Scale (HADS).
Data extraction
Titles and abstracts of identified articles were independently
screened for eligibility by two authors (S.D. and O.M.).
Full texts of potentially eligible articles were obtained and
assessed for eligibility by each reviewer according to the
aforementioned criteria. Any discrepancies were resolved
through discussion and/or consultation with the third author
(P.G.). The following data were extracted from eligible
articles: (1) study location; (2) aim(s); (3) design; (4) recruit-
ment setting; (5) survivor characteristics (age, gender, site of
tumour and treatment received); (6) QoL tool used; (7) psy-
chological predictors assessed (and tools used); (8)
assessment time-points; (9) whether or not psychological fac-
tors or their sub-components (e.g. neuroticism) were
associated with QoL in cross-sectional analyses (and, if so,
the specific results in the overall study population and sub-
groups considered); and (10) whether or not psychological
factors or their sub-components were associated with QoL
in prospective analyses (and, if so, the specific results). Where
available, results derived from multiple regression models
were extracted. Otherwise, unadjusted results were abstracted.
Quality assessment
Eligible articles were critically appraised by two authors
(S.D. and L.C.) to evaluate their risk of bias using a
150 S. Dunne et al.
Copyright © 2016 John Wiley & Sons, Ltd. Psycho-Oncology 26: 149–160 (2017)
DOI: 10.1002/pon
12-item checklist, which was based on a checklist from
previous research [17,18] supplemented by standard criti-
cal appraisal questions [19]. Articles were given a score of
2 for items marked as ‘Yes’, 1 for items marked as ‘Par-
tially’ and 0 for items marked as ‘No’ on the checklist.
Articles were considered to have good quality if they
scored 17 or more out of a maximum possible score of
24, adequate quality if they scored 9–16 and poor quality
if they scored 0–8. Where disagreement between the
appraising authors arose, consensus was achieved through
discussion. A third author (P.G.) was consulted if
disagreement persisted.
Statistical analysis
Due to heterogeneity in the analyses between the studies
described in the included articles, meta-analysis was not
undertaken.
Results
Following database searching and initial screening of titles
and abstracts, the full texts of 190 articles were assessed
for eligibility. Of these, 24 articles reporting 19 studies
fulfilled the inclusion criteria. Characteristics of, and sum-
mary results from, these studies [20–43] are provided in
Table 2. A full description of results of these studies is
provided in Table S1.
Study characteristics
The 19 studies (described in 24 articles) included 2347
patients, of whom 673 (29%) were women. Only 16 stud-
ies reported participants’ age (M=61 years, range=
23–94). Sample sizes ranged from 51 to 376 and included
HNC survivors with cancers affecting the oral cavity (n=
16), pharynx (n=15), larynx (n=12), tongue (n=6),
Table 1. Article inclusion/exclusion criteria
Inclusion criteria Exclusion criteria
1. Articles describing empirical studies with HNC survivors with a QoL measurement
instrument that was recognised as a reliable and valid measure and provided a measure
of global QoL.
1. Variables associated with QoL were clinical or related to
symptoms (e.g. pain and xerostomia).
2. Articles describing the association between QoL and at least one psychological factor. 2. Studies exclusively involving cancers of the face, ears, eyes
and thyroid.
3. QoL was measured following primary treatment. 3. Studies exclusively comprising participants receiving
palliative care.
4. Participants were at least 18 years old. 4. Qualitative studies, editorials, reviews, letters, notes,
guidelines, conference proceedings and continuing
education units.
5. Studies with QoL outcome data for N ≥ 50 HNC patients. 5. Non-English language studies.
6. Primary aim of the study was QoL instrument validation.
HNC, head and neck cancer; QoL, quality of life.
Figure 1. Papers identified, screened, assessed for eligibility and included for review
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sinuses (n=4), gums (n=3), salivary glands (n=3), nasal
cavity (n=3), inferior alveolus (n=1) and/or unknown or
unspecified primary HNC (n=13). At the time of final
QoL assessment, HNC survivors had completed their pri-
mary cancer treatment from 1 month to 7 years previously.
The eligible articles included cross-sectional (n=9) and pro-
spective (n=10) designs.2 Studies were conducted in eight
countries/regions: UK (n=7), Norway (n=2), USA (n=2),
Australia (n=2), the Netherlands (n=2), Germany (n=1),
China (n=1), Poland (n=1) and Taiwan (n=1). Participants
had received surgery, radiation, chemotherapy or a combina-
tion thereof (n=9), surgery and/or radiation (n=6), chemo-
therapy and/or radiation (n=1), surgery only (n=1),
radiation only (n=1) or treatment was not specified (n=1).
Participants were recruited from either single clinics (n=
14), multiple clinics (n=4) or support groups and profes-
sional contacts (n=1).
There was considerable heterogeneity in the question-
naires used to measure QoL: the general QoL module of
the European Organization for Research and Treatment
of Cancer Questionnaire (EORTC QLQ-C30; n=13),
EORTC HNC QoL (EORTC QLQ-H&N35; n=9), Uni-
versity of Washington Quality of Life Questionnaire
(UW-QoL; n=7), Functional Assessment of Cancer
Therapy – Head and Neck Scale (FACT-HN; n=3), Med-
ical Outcomes Study Short Form (12) Health Survey
(MOS SF-12; n=3), FACT General Scale (FACT-G;
n=2), World Health Organization Quality of Life Scale –
Abbreviated Version (WHOQoL-Bref; n=1) and/or
Patient Generated Index (PGI; n=1). There was also con-
siderable diversity in the psychological variables examined
and the assessment instruments used to measure them.
Distress-related variables (i.e. depression, anxiety or
combined distress scores) were the most commonly
assessed psychological factors (n=10) and were measured
using the HADS, Beck Depression Inventory (BDI), Gen-
eral Health Questionnaire (GHQ), Self-Rating Depression
Scale (SDS) or Self-Rating Anxiety Scale (SAS). Coping
was examined in six studies with the Coping Orientations
to Problems Experienced (COPE), Brief COPE, Ways of
Coping – Cancer Version (WOC-CV), Medical Coping
Modes Questionnaire (MCMQ) or Freiburg Questionnaire
on Coping with Illness (FCQI). Personality was assessed in
five studies with the Eysenck Personality Inventory (EPI),
Life Orientation Test –Revised (LOT-R) or Millon Behav-
ioral Health Inventory (MBHI). HNC survivors’ percep-
tions of the care they received was examined in four
studies, using the Satisfaction with Information Profile
(SCIP; n=2), the Social Support Questionnaire (SSQ;
n=1) and three non-validated questions relating to
perceived burden of care in the remaining study [39]. Fear
of recurrence was assessed in two studies with two
different unvalidated measures [24,38]. Two additional
psychological variables were assessed in a single study
each: body image using the Derriford Appearance Scale
(DAS24) and benefit-finding (i.e. seeking benefit from ad-
verse experiences) using the Benefit Finding Scale (BFS).
All included studies demonstrated a significant relation-
ship between at least one psychological factor and post-
treatment QoL outcomes. Of the 15 articles describing
10 studies with prospective designs, only six articles
describing five studies [21,23,27,30,33,34] reported
longitudinal analyses in relation to psychological predic-
tors of QoL (i.e. where the psychological factor was mea-
sured before the QoL outcome), while the other nine
articles describing seven studies [20,22,25,32,35–38,43]
reported only cross-sectional associations between
psychological factors and QoL in the post-treatment
period. The remaining nine articles describing nine studies
[24,26,28,29,37,39–42] reported on cross-sectional asso-
ciations between at least one psychological factor and
post-treatment QoL outcomes.
Cross-sectional analyses
Distress-related variables
The cross-sectional relationship between depression and QoL
was examined in five studies [24,28,32,36,42]. In each study,
higher depression scores among HNC survivors were signif-
icantly associated with poorer QoL outcomes, including
lower physical, mental and social functioning and higher
generic and HNC-specific symptom scores in four stud-
ies [24,28,36,42]; lower emotional well-being in three studies
[24,28,32]; and lower global or overall QoL in two studies
[24,28]. Four studies also examined the relationship between
anxiety and QoL among HNC survivors cross sectionally
[28,30,36,42]. Higher levels of anxiety were associated with
higher generic and HNC-specific symptom scores in three
studies [28,36,42], lower social functioning in two studies
[28,42], lower overall QoL in two studies [28,30] and lower
physical functioning, mental functioning and emotional well-
being scores in one study [28]. A significant interaction
between anxiety and gender in relation to QoL among naso-
pharyngeal carcinoma survivors was observed in one study
[30]; anxious females (who scored >11 on the anxiety sub-
scale of the HADS) exhibited significantly lower QoL com-
pared with non-anxious women, while anxious men did not
display significantly lower QoL than non-anxious men.
Finally, the relationship between distress (combined anxiety
and depression scores) and QoL was examined in three stud-
ies [23,25,43]. Higher distress was significantly associated
with higher HNC-specific symptom scores in all three studies
[23,25,43] as well as lower physical functioning and emo-
tional well-being scores and higher generic symptom scores
in two studies [23,43].
Coping
Five studies examined associations between coping and QoL
through cross-sectional analyses [20–23,26,30,37,38,40]. In
two studies using the COPE, avoidance coping was
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associated with poorer QoL outcomes, including lower func-
tioning and global QoL [20–23,37,38] and higher generic
and HNC-specific symptom scores [20–23], while
problem-focused coping was associated with poorer func-
tional QoL, general cancer symptom QoL and HNC-specific
symptom QoL [20–23]. In one of these studies, ‘drinking to
cope’ was negatively associated with global and functional
QoL [21]; in the other, coping through humour was nega-
tively associated with functional QoL outcomes and posi-
tively associated with general and HNC-specific symptoms
[22]. In a study using the MCMQ [30], lower confrontation
coping was associated with poorer total QoL scores. Another
study found that all five patterns of coping from the WOC-
CV (seeking or using social support, distancing, cognitive
escape-avoidance, behavioural escape-avoidance and focus-
ing on the positive) were associated with poorer QoL
outcomes among laryngectomy survivors [26]. Finally, one
study [40] found that ‘depressive coping’ measured with the
FCQI had a significant negative association with overall QoL.
Personality
Two studies assessed personality using the EPI [20–
23,37,38]. In both studies, cross-sectional analyses indicated
that high neuroticism scores were associated with poorer
QoL outcomes in all domains of both EORTC QoL scales.
Additionally, in both studies, greater neuroticism was a sig-
nificant independent predictor of lower functional QoL and
higher HNC-specific symptoms [21,23].
Perceptions of care received
Four studies examined the relationship between QoL and
variables, which measured HNC survivors’ perceptions of
the care they received, specifically, survivors’ satisfaction
with their care [33,34], perceived burden on carers [39]
and satisfaction with the social support they received [29].
The findings of two articles derived from the same study
[33,34] indicated that higher levels of patient satisfaction
with information on illness and treatment measured before
and after treatment predicted better mental functioning
QoL. In another study [39], a range of variables measuring
survivors’ perceptions of the burden of care they placed on
their caregiver were related to poorer functional QoL out-
comes; that is, patients with poorer functioning felt they
were a greater burden on their carers. Finally, in one study
[29], a combination of greater satisfaction with social sup-
port (as measured by the SSQ) and lower premorbid pessi-
mism (as measured by the MBHI) predicted higher
social/family well-being among this cohort.
Fear of recurrence
Fear of recurrence and QoL were assessed in cross-sectional
analyses in two studies [27,41]. In one study, greater FoR
(assessed using a single item) was significantly associated
with lower overall QoL [41]. In the other, greater FoR
(assessed using a seven-item questionnaire) was associated
with lower social and emotional functioning [27].
Other psychological factors
In one study [31], greater body image concerns were asso-
ciated with poorer QoL in all domains of the UW-QoL.
One further study [35] found that the emotional and spir-
itual growth item in the benefit-finding scale (i.e. deriving
emotional or spiritual growth from HNC) was associated
with higher levels of mental health-related QoL.
Longitudinal analyses
Five studies [21,23,27,30,33,34] provided longitudinal
analyses of psychological factors and QoL. Two of these
studies examined the relationship between anxiety (mea-
sured by the HADS) and subsequent QoL. In one study
[30], HNC survivors with high levels of anxiety before
radiotherapy had the greatest decline in QoL following
treatment. The other study [34] found that anxiety, opti-
mism (measured by the LOT-R) and patient satisfaction
at diagnosis predicted mental functioning QoL scores 6–
8 months following treatment. The longitudinal associa-
tion between distress and QoL was also examined in one
study [23]; distress levels (measured by the GHQ) at least
1 year post-treatment were associated with poor QoL out-
comes among HNC survivors 3 years later. Two studies
[21,23] investigated the relationship between personality
and coping (measured by the EPI and COPE,
respectively) after treatment and subsequent QoL out-
comes. Both studies reported that higher levels of neurot-
icism, problem-focused coping and avoidance-focused
coping immediately after treatment predicted lower func-
tional and global QoL and higher generic and HNC-
specific symptoms 3 or more years later. One of these
studies [21] also found that ‘drinking to cope’ and ‘coping
by humour’ measured 4 years post-treatment were associ-
ated with poor QoL outcomes up to 4 years later. One ad-
ditional study, which examined the longitudinal
relationship between coping and QoL, found that accep-
tance coping at diagnosis (measured by the Brief COPE)
predicted global QoL 6–8 months following treatment
when combined with tumour stage and pre-treatment
QoL [34]. Two studies [33,34] found that higher levels
of patient satisfaction at diagnosis (measured by SCIP)
predicted better mental functioning QoL 6–8 months fol-
lowing treatment. Finally, one study [27] found that an in-
crease in FoR from an initial post-treatment visit to
approximately 7 months later was associated with worsen-
ing anxiety-related QoL scores at least 7 months later.
Quality assessment
The quality assessment is summarised in Table 1 (with
further details in Table S2). Eight articles were scored as
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‘good quality’, 15 were rated as ‘adequate quality’ and
one was rated as ‘poor quality’. Areas in which articles
scored poorly included failure to justify sample size, not
having a control group, not justifying statistical practices
(e.g. dichotomizing scores on psychological variables into
binary predictors without providing a rationale) and poor
descriptions of the population, design, recruitment
strategy and characteristics of non-responders/non-
participants.
Conclusions
The current review builds on the findings of a prior
systematic review [15] to demonstrate that several key
psychological factors significantly predict QoL among
HNC survivors. As observed previously, depression and
neuroticism were important predictors of negative QoL
outcomes in HNC research published in the last 10 years.
The current review extends the findings of this previous
review by providing evidence that anxiety, distress, FoR
and coping style are also strongly associated with poor
QoL outcomes among HNC survivors following treat-
ment. In line with this prior review [15], two measures
of perceptions of care received, patient satisfaction
[41,42] and satisfaction with social support [29], were also
associated with positive QoL outcomes. However, the
limited evidence available suggests that further investiga-
tion of these associations is warranted. Some limited data
from individual studies also suggest that other psycholog-
ical variables such as body image [31], benefit-finding
[35] and perceived burden of care [39] may have signifi-
cant associations with QoL. These findings, together with
the wider body of literature on these variables [e.g. 44–
46], suggest promising avenues for further research and
the potential for future intervention development among
HNC survivors. In particular, it is likely that body image
may be an important predictor of QoL outcomes among
this cohort given the potential for visible disfigurement
following HNC treatment. Nonetheless, the quality assess-
ment indicated a number of shortcomings in many studies,
including limited description of the population, design and
recruitment strategies, limited justification of statistical
practices and potential bias in the reporting of significant
findings; suggesting that, a decade on from the review of
Llewellyn et al. [15], there remains limited high-quality
research investigating the psychological factors that pre-
dict QoL among HNC survivors. Furthermore, the find-
ings from the quality assessment mean that the study
results should be interpreted with caution and care taken
when considering the full implications of the findings
described herein.
In this review, distress-related variables were consis-
tently associated with poorer QoL outcomes among
post-treatment HNC survivors in cross-sectional and lon-
gitudinal analyses. Prior to 2005, research investigating
the impact of distress-related variables on QoL in HNC
typically focused on depression [15], and variables such
as anxiety and emotional distress had rarely been
examined. Consistent with the findings of this research,
in the current review, depression was associated with
poorer QoL outcomes in cross-sectional analyses
[24,28,32,36,42]. A novel finding of this review is that
higher anxiety levels were similarly associated with a
range of poorer QoL outcomes across five studies
[28,30,34,36,42], and distress (combined anxiety and
depression scores) was associated with impaired QoL
among HNC survivors in three studies [22,25,43]. These
findings are consistent with the broader cancer survivor-
ship literature, where both depression and anxiety have
been associated with lower QoL among diverse groups
of cancer survivors including those with breast, colorectal
and lung cancer [47–49]. However, it should be noted that
clinical assessments of depression, anxiety and/or distress
were not undertaken in these studies. In line with recom-
mendations from prior systematic reviews and clinical
guidelines for HNC care pathways [50–53], routine clini-
cal screening for both depression and anxiety (or distress)
by practitioners could enable the identification of individ-
uals at risk for poorer QoL outcomes following HNC
treatment and who might benefit from intervention
and/or support. In particular, while depression and anxiety
are known to occur at all stages of the disease trajectory
among HNC survivors [6], it may be important to identify
individuals who exhibit clinical symptoms of distress
post-treatment and may benefit from formal psychological
support [50].
A further novel finding of the current review is the pres-
ence of strong negative associations between FoR and
post-treatment QoL outcomes across two studies [27,43].
FoR represents a particularly important area for study
among this survivor population given that recurrence risk
is high in HNC [54–56]. While the current findings need
replication in larger populations, employing more
standardised and psychometrically robust measures of this
construct (such as the Fear of Progression Questionnaire
or the shorter Assessment of Survivor Concerns Scale
[57]) would also be useful. It has been estimated that
between half and three-quarters of this population have
concerns about recurrence [6]. Interventions that target
the management of FoR concerns (e.g. through active
emotion-focused and behavioural strategies to manage
uncertainty fears) may increase QoL among HNC survi-
vors where recurrence fears have become intrusive
[58,59]. Indeed, such interventions have been successful
among other groups of cancer survivors [e.g. 59].
This review also reveals a striking negative relationship
between the use of specific coping strategies and QoL out-
comes among HNC survivors. Indeed, a range of both
active (coping with humour, seeking or using social sup-
port, focusing on the positive and acceptance coping)
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and avoidant coping strategies (coping by suppression of
competing activities, coping by behavioural avoidance,
drinking to cope, cognitive escape-avoidance, behavioural
escape-avoidance, low confrontation coping and depres-
sive coping) were associated with poorer QoL outcomes
among HNC survivors in both cross-sectional and longitu-
dinal analyses [20–23,26,30,34,37,38,40]. It is unclear
exactly why both active and avoidant coping strategies
are associated with poorer QoL outcomes among HNC
survivors, but interestingly, similar associations have been
reported among prostate cancer survivors (e.g. [60,61]).
Aarstad et al. [21] propose that such findings may indicate
that HNC survivors who perceive they have poorer QoL
employ more attempts to cope with these challenges,
thereby more vigorously applying a variety of coping
strategies. While this cannot explain longitudinal associa-
tions between active and avoidant coping strategies and
subsequent QoL, it should be noted that the two studies
in the current review, which examined longitudinal associ-
ations between active and avoidant coping strategies and
QoL [21,23], did not measure coping strategies at more
than one time point, and it is possible that coping strate-
gies employed by HNC survivors may change over time.
Because emerging research has indicated that the QoL of
HNC survivors may stabilise or improve beyond baseline
levels approximately 5 years after HNC treatment [62,63]
or may deteriorate over time due to late effects [64,65], it
would be useful to establish whether individual active and
avoidant coping strategies interact with QoL outcomes
over time in order to identify time points across the post-
treatment trajectory when interventions to improve HNC
survivors’ coping skills would be most appropriate.
The findings from the studies included in this review
give a somewhat more limited picture of the relationship
between personality variables and QoL. Neuroticism was
associated with lower QoL outcomes in both cross-
sectional and longitudinal analyses across two studies
from a Norwegian research group [21–23,37,38].
Together with the findings of the review of Llewellyn
et al. [15], these results point towards a consistent associ-
ation between neuroticism and poor QoL outcomes among
HNC survivors. In terms of potential explanations for this
relationship, neuroticism is typically associated with more
negative health perceptions generally (e.g. [66–68]). In
one study [34], optimism measured at diagnosis was asso-
ciated with improved mental functioning QoL following
treatment. However, other personality variables such as
agreeableness, conscientiousness and impulsivity have
not been investigated, suggesting that further research is
needed to identify whether additional personality factors
such as these may affect the QoL of HNC survivors fol-
lowing treatment.
A major finding of the current review is the wide het-
erogeneity in measurement, sampling and design between
studies; indeed, the heterogeneity was so great as to
preclude formal statistical combination of the studies. In
general, there was great diversity in QoL measures used,
and these different QoL measures incorporate specific
sub-domains of QoL, which cannot be easily compared
as they may be tapping into different aspects of QoL.
There is currently no recognised gold standard measure
for QoL in HNC [10]; future research would benefit from
the development of more standardised approaches to QoL
measurement among this population. There was also
diversity in the sample size and composition of included
studies. Notably, sample sizes were relatively small, with
the largest study including less than 400 participants. Fur-
thermore, recruitment strategies were not documented in
many studies and most recruited from single (or a small
number) of clinics, raising the possibility that results
may not be generalizable to the wider population of
HNC survivors. Larger population-based studies investi-
gating the psychological factors that predict QoL out-
comes among HNC survivors are needed to establish the
veracity of the findings described herein, to ensure ade-
quate power and enable informative analyses of HNC sub-
groups or interactions between psychological and other
predictors of QoL. Finally, it should be noted that several
studies included in the current review reported only mod-
est associations between psychological variables and QoL.
Greater efforts should be made in future studies to provide
further information on design and recruitment strategies,
justify statistical practices, discuss non-significant find-
ings in detail and clarify the strength of associations
between psychological variables and QoL in order to
enhance their replicability and demonstrate that they are
free from bias.
While this review has identified important directions for
future HNC survivorship research and intervention devel-
opment, it has a number of limitations. Firstly, the review
is limited to studies published in the English language.
There may be additional relevant research that has been
published in other languages. Additionally, this review is
restricted to examining psychological predictors of QoL
in the post-treatment period alone, and the findings may
not apply to HNC patients undergoing or awaiting treat-
ment. However, a wealth of evidence suggests that the
post-primary treatment phase is a unique period of intense
vulnerability for HNC survivors, characterised by lower
QoL [5,6,11], and thus merits individual attention.
In conclusion, this review shows that there are strong
negative associations between distress-related variables
and the QoL of HNC survivors following their treatment.
Interventions to reduce distress may help to improve HNC
survivors’ QoL, and routine screening for distress may
identify those at risk for poor QoL in this period. How-
ever, there is a need for further longitudinal and
population-based studies, which take more systematic
and standardised measurement approaches to better under-
stand the relationship between QoL and other
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psychological variables among post-treatment HNC survi-
vors. Such studies could inform the development of inter-
ventions and supportive care strategies to improve QoL in
this population.
Notes
1. In clinical practice, QoL typically refers to health-
related QoL, which comprises aspects of QoL
related to health or medical concerns, and measures
physical, psychological and social domains [15].
For this review, we have opted for the more general
term ‘quality of life’, which may refer to both QoL
and health-related QoL, as these terms are often used
interchangeably in the literature.
2. Studies were classified as prospective if at least one
psychological factor was measured at a time point
that preceded the QoL measurement.
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